how glp-1 drugs work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review GLP-1 drugs are making waves
Description
Alhajahjeh, A
Cardiometabolic complications are inside the indication, not adjacent to it
Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management in adults with obesity
Cagrisema is a dual therapy that combines semaglutide, a GLP-1 receptor agonist, with cagrilintide, a long-acting insulin analog
